BioProcess360

Abselion develops biosensor technologies for rapid, cost-effective detection of biomolecules, including proteins, DNA, and small molecules. The company provides diagnostic analyzers and kits that simplify analysis of biomolecular interactions, supporting pharmaceutical research and manufacturing. Its platform enables sensitive, near real-time monitoring of interactions such as protein binding, helping researchers obtain timely data to inform experiments, diagnostics, and development pipelines.

Founded in Munich, Germany in 2017, IRUBIS specializes in manufacturing Mid-Infrared (MIR) spectrometers and Attenuated Total Reflection (ATR) crystals. The company combines semiconductor technology with infrared spectroscopy to develop devices for analyzing protein-based drugs. IRUBIS offers a real-time bioprocess monitoring system using MIR spectroscopy, which measures glucose and lactate online without contamination risk. They also provide ATR crystals and accessory solutions.